PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER (NDA206056)- (EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL,EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL,EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL)

Generic Name	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	Innovator	B BRAUN MEDICAL INC
Dosage	EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL,EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL,EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL	**	**	-	-	-
EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL	**	**	-	-	-
EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER